CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 4 Open-market buy Director bought 2,500 shares at $10.96 ($27,389)
- 4 Exercise or conversion Ex Vice President of Research acquired 40,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $9.74 ($9,740)
- 4 Open-market sale Chief Medical Officer sold 40,000 shares at $13.49 ($539,600)
- 4 Open-market buy Director bought 5,000 shares at $13.00 ($65,000)
- 4 Open-market buy Director bought 1,600 shares at $16.03 ($25,648)
- 4 Exercise or conversion Director acquired 95,000 shares (option exercise)
- 4 Open-market buy EVP, General Counsel bought 900 shares at $16.14 ($14,526)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 9 of 10 · 184 filings